Delivery Order SPE2DB22D3301-SPE2DB25FZ1LV
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, PA, was awarded a delivery order valued at $10,662.57 by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by May 12, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government. The award was...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price arrangement with a ceiling value of $42,650.28 and an ultimate completion date of June 27, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of the federal government's reliance on AmerisourceBergen as a critical pharmaceutical distributor for...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Tagrisso 80 mg tablets (30-count units) with a contract ceiling value of $10,662.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 1, 2025, awarded on September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $21,325.14 on September 5, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of September 26, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) valued at $10,662.57 under a firm fixed price contract. This delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX and valued at $999,999,999.00 through December 2026), represents a competitive, non-set-aside award with an ultimate...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price contract, classified as a non-set-aside competitive award, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's Conshohocken,...
- AmerisourceBergen Drug Corp received a $63,975.42 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain to deliver Tagrisso 80 mg tablets (30-count units) for military healthcare applications. Awarded on September 18, 2025, with an ultimate completion date of October 9, 2025, this non-set-aside contract represents a competitively awarded procurement of this oncology medication. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $53,312.85 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 9, 2025, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of September 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $31,987.71 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Tagrisso 80 mg tablets under a firm fixed price contract. This delivery order, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 20, 2025, for the supply of TAGRISSO 80 mg tablets (30-count units) with a contract value of $10,662.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 11, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1LVDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,650.28 for Tagrisso 80 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, leveraging the company's role as a critical distributor for military and veteran healthcare systems. This contract operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this flexible contract structure, AmerisourceBergen supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a primary vendor within the DLA Medical Supply Chain for diverse therapeutic domains and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.7k | 9/24/25 |